Cargando…

Pathological severity determines the renal recovery for anti-myeloperoxidase antibody-associated vasculitis requiring dialysis at disease onset: a retrospective study

BACKGROUND: Many patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) need dialysis at disease onset due to severe kidney injury. Determining whether they can become dialysis independent is an important clinical assessment. METHODS: Forty kidney biopsy-proved myelope...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Peng-cheng, Chen, Tong, Wu, Si-jing, Yang, Xia, Gao, Shan, Hu, Shui-yi, Wei, Li, Yan, Tie-kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668067/
https://www.ncbi.nlm.nih.gov/pubmed/31362703
http://dx.doi.org/10.1186/s12882-019-1487-7
_version_ 1783440148534394880
author Xu, Peng-cheng
Chen, Tong
Wu, Si-jing
Yang, Xia
Gao, Shan
Hu, Shui-yi
Wei, Li
Yan, Tie-kun
author_facet Xu, Peng-cheng
Chen, Tong
Wu, Si-jing
Yang, Xia
Gao, Shan
Hu, Shui-yi
Wei, Li
Yan, Tie-kun
author_sort Xu, Peng-cheng
collection PubMed
description BACKGROUND: Many patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) need dialysis at disease onset due to severe kidney injury. Determining whether they can become dialysis independent is an important clinical assessment. METHODS: Forty kidney biopsy-proved myeloperoxidase (MPO)-ANCA associated AAV patients who required dialysis at disease onset were enrolled. Relationships between laboratory and pathological characteristics and prognoses were analyzed. RESULTS: Twenty-five patients obtained dialysis independence within 3 months, while the other 15 patients remained dialysis dependent. No sclerotic class was identified among the 40 patients. Only two biopsies exhibited focal class diagnoses and both these patients recovered their renal function. The renal recovery rate of the 20 patients with mixed class was significantly lower than that of the 18 patients with crescentic class (40.0% vs. 83.3%, p = 0.006). Receiver operating characteristics (ROC) curves showed fibrous crescent+global glomerulosclerosis greater than 32.6% was a strong predictor of dialysis dependence with a sensitivity of 93.3% and specificity of 88.0%. When the percentage of fibrous crescent+global glomerulosclerosis exceeded 47.9%, dialysis independence was not possible. Correlation analysis indicated that platelet counts were negatively correlated with the percentage of fibrous crescent+global glomerulosclerosis (R = -0.448, p = 0.004). Most patients with increased platelets (84.62%) obtained renal recovery. Compared with methylprednisolone pulse therapy, plasma exchange accelerated renal recovery (29.4 ± 15.6 vs. 41.4 ± 11.7 days, p = 0.039). CONCLUSIONS: For MPO-ANCA AAV who required dialysis at disease onset, crescentic and mixed classes accounted for the majority of patients in our cohort. The renal outcome of mixed class patients was worse than that of crescentic class. A high proportion of fibrous crescent+global glomerulosclerosis is a predictor of dialysis dependence. Increased platelet count is associated with active and reversible renal lesions.
format Online
Article
Text
id pubmed-6668067
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66680672019-08-05 Pathological severity determines the renal recovery for anti-myeloperoxidase antibody-associated vasculitis requiring dialysis at disease onset: a retrospective study Xu, Peng-cheng Chen, Tong Wu, Si-jing Yang, Xia Gao, Shan Hu, Shui-yi Wei, Li Yan, Tie-kun BMC Nephrol Research Article BACKGROUND: Many patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) need dialysis at disease onset due to severe kidney injury. Determining whether they can become dialysis independent is an important clinical assessment. METHODS: Forty kidney biopsy-proved myeloperoxidase (MPO)-ANCA associated AAV patients who required dialysis at disease onset were enrolled. Relationships between laboratory and pathological characteristics and prognoses were analyzed. RESULTS: Twenty-five patients obtained dialysis independence within 3 months, while the other 15 patients remained dialysis dependent. No sclerotic class was identified among the 40 patients. Only two biopsies exhibited focal class diagnoses and both these patients recovered their renal function. The renal recovery rate of the 20 patients with mixed class was significantly lower than that of the 18 patients with crescentic class (40.0% vs. 83.3%, p = 0.006). Receiver operating characteristics (ROC) curves showed fibrous crescent+global glomerulosclerosis greater than 32.6% was a strong predictor of dialysis dependence with a sensitivity of 93.3% and specificity of 88.0%. When the percentage of fibrous crescent+global glomerulosclerosis exceeded 47.9%, dialysis independence was not possible. Correlation analysis indicated that platelet counts were negatively correlated with the percentage of fibrous crescent+global glomerulosclerosis (R = -0.448, p = 0.004). Most patients with increased platelets (84.62%) obtained renal recovery. Compared with methylprednisolone pulse therapy, plasma exchange accelerated renal recovery (29.4 ± 15.6 vs. 41.4 ± 11.7 days, p = 0.039). CONCLUSIONS: For MPO-ANCA AAV who required dialysis at disease onset, crescentic and mixed classes accounted for the majority of patients in our cohort. The renal outcome of mixed class patients was worse than that of crescentic class. A high proportion of fibrous crescent+global glomerulosclerosis is a predictor of dialysis dependence. Increased platelet count is associated with active and reversible renal lesions. BioMed Central 2019-07-30 /pmc/articles/PMC6668067/ /pubmed/31362703 http://dx.doi.org/10.1186/s12882-019-1487-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Xu, Peng-cheng
Chen, Tong
Wu, Si-jing
Yang, Xia
Gao, Shan
Hu, Shui-yi
Wei, Li
Yan, Tie-kun
Pathological severity determines the renal recovery for anti-myeloperoxidase antibody-associated vasculitis requiring dialysis at disease onset: a retrospective study
title Pathological severity determines the renal recovery for anti-myeloperoxidase antibody-associated vasculitis requiring dialysis at disease onset: a retrospective study
title_full Pathological severity determines the renal recovery for anti-myeloperoxidase antibody-associated vasculitis requiring dialysis at disease onset: a retrospective study
title_fullStr Pathological severity determines the renal recovery for anti-myeloperoxidase antibody-associated vasculitis requiring dialysis at disease onset: a retrospective study
title_full_unstemmed Pathological severity determines the renal recovery for anti-myeloperoxidase antibody-associated vasculitis requiring dialysis at disease onset: a retrospective study
title_short Pathological severity determines the renal recovery for anti-myeloperoxidase antibody-associated vasculitis requiring dialysis at disease onset: a retrospective study
title_sort pathological severity determines the renal recovery for anti-myeloperoxidase antibody-associated vasculitis requiring dialysis at disease onset: a retrospective study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668067/
https://www.ncbi.nlm.nih.gov/pubmed/31362703
http://dx.doi.org/10.1186/s12882-019-1487-7
work_keys_str_mv AT xupengcheng pathologicalseveritydeterminestherenalrecoveryforantimyeloperoxidaseantibodyassociatedvasculitisrequiringdialysisatdiseaseonsetaretrospectivestudy
AT chentong pathologicalseveritydeterminestherenalrecoveryforantimyeloperoxidaseantibodyassociatedvasculitisrequiringdialysisatdiseaseonsetaretrospectivestudy
AT wusijing pathologicalseveritydeterminestherenalrecoveryforantimyeloperoxidaseantibodyassociatedvasculitisrequiringdialysisatdiseaseonsetaretrospectivestudy
AT yangxia pathologicalseveritydeterminestherenalrecoveryforantimyeloperoxidaseantibodyassociatedvasculitisrequiringdialysisatdiseaseonsetaretrospectivestudy
AT gaoshan pathologicalseveritydeterminestherenalrecoveryforantimyeloperoxidaseantibodyassociatedvasculitisrequiringdialysisatdiseaseonsetaretrospectivestudy
AT hushuiyi pathologicalseveritydeterminestherenalrecoveryforantimyeloperoxidaseantibodyassociatedvasculitisrequiringdialysisatdiseaseonsetaretrospectivestudy
AT weili pathologicalseveritydeterminestherenalrecoveryforantimyeloperoxidaseantibodyassociatedvasculitisrequiringdialysisatdiseaseonsetaretrospectivestudy
AT yantiekun pathologicalseveritydeterminestherenalrecoveryforantimyeloperoxidaseantibodyassociatedvasculitisrequiringdialysisatdiseaseonsetaretrospectivestudy